B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.

about

B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.

Item

http://www.wikidata.org/entity/Q52334544

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@en

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@nl

type

Item

label

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@en

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@nl

prefLabel

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@en

B-cell activity markers are as ...... in primary Sjögren's syndrome.

@nl

P1476

B-cell activity markers are as ...... in primary Sjögren's syndrome

@en

P2093

Antony Parker

http://www.w3.org/2001/XMLSchema#string

Benjamin A Fisher

http://www.w3.org/2001/XMLSchema#string

Chimwemwe Chipeta

http://www.w3.org/2001/XMLSchema#string

Colin S Gillespie

http://www.w3.org/2001/XMLSchema#string

Francesca Barone

http://www.w3.org/2001/XMLSchema#string

Jennifer Hallinan

http://www.w3.org/2001/XMLSchema#string

Simon J Bowman

http://www.w3.org/2001/XMLSchema#string

Stephen Harding

http://www.w3.org/2001/XMLSchema#string

UK Primary Sjögren’s Syndrome Registry

http://www.w3.org/2001/XMLSchema#string

Wan-Fai Ng

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.

Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome

Free immunoglobulin light chain: its biology and implications in diseases.

A review of salivary gland histopathology in primary Sjögren's syndrome with a focus on its potential as a clinical trials biomarker.

Renal involvement in primary Sjögren syndrome.

Lymphocyte antigens targetable by monoclonal antibodies in non-systemic vasculitic neuropathy.

Secreted autoantibody repertoires in Sjögren's syndrome and systemic lupus erythematosus: A proteomic approach.

P304

1222-1227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/RHEUMATOLOGY/KEY063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon J. Cockell

Katherine James

P577

2018-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29608774

http://www.w3.org/2001/XMLSchema#string

P932

6014143

http://www.w3.org/2001/XMLSchema#string